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Processes for the preparation of ({(12aR)-12-[(11S)-7,8-difluoro-6,11-dihydrodibenzo
[b,e]thiepin-11-yl]-6,8-dioxo-3,4,6,8,12,12a-hexahydro-1H-[1,4]oxazino[3,4-c]pyrido
[2,1-f][1,2,4]triazin-7-yl}oxy)methyl methyl carbonate

5

Field of the Invention:
The present invention provides various processes for the preparation of ({(12aR)-12[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin11-yl]-6,8-dioxo-3,4,6,8,12,12ahexahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazin-7-yl}oxy)methyl

methyl

carbonate represented by the following structural formula-1.

10

Formula-1
Background of the Invention:
({(12aR)-12-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin11-yl]-6,8-dioxo3,4,6,8,12,12a-hexahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazin-7-yl}oxy)methyl

15

methyl carbonate is commonly known as Baloxavir marboxil.
Baloxavir marboxil is designed and developed by Genentech Inc. It is a polymerase
acidic (PA) endonuclease inhibitor indicated for the treatment of acute uncomplicated
influenza in patients 12 years of age and older who have been symptomatic for no more than
48 hours. Baloxavir marboxil is approved by USFDA on Oct 24, 2018 and is being marketed

20

under the brand name XOFLUZA™.
US10392406B2 specifically describes Baloxavir marboxil, its intermediates and
processes for preparation thereof.
Still, there is a significant need in the art for the development of novel processes for

25

the preparation of Baloxavir marboxil.

1
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Brief description of the invention:
The first embodiment of the present invention is to provide a process for the
preparation of compound of formula-1.
The second embodiment of the present invention is to provide a process for the
5

preparation of compound of formula-1 involving the use of compound of formula-38 as
illustrated in scheme-I.
The third embodiment of the present invention is to provide another process for the
preparation of compound of formula-1.
The fourth embodiment of the present invention is to provide a process for the

10

preparation of compound of formula-1 involving the use of compound of formula-27 as
illustrated in scheme-III.
The fifth embodiment of the present invention is to provide a process for the
preparation of compound of formula-29.
The sixth embodiment of the present invention is to provide a process for the

15

preparation of compound of formula-1 involving the use of compound of formula-33 as
illustrated in scheme-IV.
The seventh embodiment of the present invention is to provide a process for the
preparation of compound of formula-1 involving the use of compound of formula-35 as
illustrated in scheme-IV.

20
Detailed description of the Invention:
The "solvent" used in the present invention can be selected from but not limited to
"hydrocarbon solvents" such as n-pentane, n-hexane, n-heptane, cyclohexane, petroleum
ether, benzene, toluene, xylene and the like; "ether solvents" such as dimethyl ether, diethyl
25

ether, diisopropyl ether, methyl tert-butyl ether, 1,2-dimethoxyethane, tetrahydrofuran, 1,4dioxane and the like; "ester solvents" such as methyl acetate, ethyl acetate, n-propyl acetate,
isopropyl acetate, n-butyl acetate, isobutyl acetate, tert-butyl acetate and the like; "polaraprotic solvents" such as dimethylacetamide, dimethylformamide, dimethylsulfoxide, Nmethylpyrrolidone (NMP) and the like; "chloro solvents" such as dichloromethane,

30

dichloroethane, chloroform, carbon tetrachloride and the like; "ketone solvents" such as
2
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acetone, methyl ethyl ketone, methyl isobutyl ketone and the like; "nitrile solvents" such as
acetonitrile, propionitrile, isobutyronitrile and the like; "alcohol solvents" such as methanol,
ethanol, n-propanol, iso-propanol, n-butanol, iso-butanol, 2-butanol, tert-butanol, ethane-1,2diol, propane-1,2-diol and the like; "polar solvents" such as water; formic acid, acetic acid
5

and the like or mixture of any of the afore mentioned solvents.
Various conversions/steps in the processes of the present invention can be carried out
in the presence or absence of a solvent or mixture of solvents. The said solvent(s) can be
selected from those as described above.
The "base" used in the present invention can be selected from but not limited to

10

"inorganic bases" selected from "alkali metal carbonates" such as sodium carbonate,
potassium carbonate, lithium carbonate, cesium carbonate and the like; "alkali metal
bicarbonates" such as sodium bicarbonate, potassium bicarbonate, lithium bicarbonate,
cesium bicarbonate and the like; "alkali metal hydroxides" such as sodium hydroxide,
potassium hydroxide, lithium hydroxide, cesium hydroxide and the like; "alkali metal

15

hydrides" such as sodium hydride, potassium hydride, lithium hydride and the like; "alkali
metal amides" such as sodium amide, potassium amide, lithium amide and the like;
ammonia; "organic bases" like "alkali metal alkoxides" such as sodium methoxide, sodium
ethoxide, potassium methoxide, potassium ethoxide, lithium methoxide, lithium ethoxide,
sodium tert.butoxide, potassium tert.butoxide, lithium tert.butoxide and the like; alkali metal

20

and alkali earth metal salts of acetic acid such as sodium acetate, potassium acetate,
magnesium acetate, calcium acetate and the like; dimethylamine, diethylamine, diisopropyl
mine, diisopropylethylamine (DIPEA), diisobutylamine, trimethylamine, triethylamine,
triisopropylamine, tributylamine, tert.butyl amine, pyridine, piperidine, 4-dimethylamino
pyridine (DMAP), quinoline, imidazole, N-methylimidazole, l,8-diazabicyclo[5.4.0]undec-7-

25

ene (DBU), l,5-diazabicyclo[4.3.0]non-5-ene (DBN), dimethylaniline, N-methylmorpholine
(NMM), l,4-diazabicyclo[2.2.2]octane (DABCO), 2,6-lutidine and the like; "organolithium
bases" such as methyl lithium, n-butyl lithium, lithium diisopropylamide (LDA) and the like;
"organosilicon

bases"

such

as

lithium

hexamethyldisilazide

(LiHMDS),

sodium

hexamethyldisilazide (NaHMDS), potassium hexamethyldisilazide (KHMDS) and the like or
30

mixtures thereof.
3
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The „acid‟ used in the present invention can be selected from but not limited to
"inorganic acids" such as hydrofluoric acid, hydrochloric acid, hydrobromic acid, sulfuric
acid, nitric acid, phosphoric acid, boric acid, perchloric acid, carbonic acid and the like; and
"organic acids" such as formic acid, acetic acid, trifluoroacetic acid, propionic acid, butyric
5

acid, valeric acid, substituted/unsubstituted alkyl/aryl sulfonic acids such as methanesulfonic
acid, ethanesulfonic acid, propanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid,
naphthalenesulfonic acid and the like.
The „„base” used in the present invention for hydrolysis step can be selected from but
not limited to alkali metal hydroxides such as lithium hydroxide, sodium hydroxide,

10

potassium hydroxide, cesium hydroxide and the like; alkaline earth metal hydroxides such as
barium hydroxide, strontium hydroxide, magnesium hydroxide, calcium hydroxide and the
like; alkali metal carbonates such as sodium carbonate, potassium carbonate, lithium
carbonate, cesium carbonate and the like; alkaline earth metal carbonates such as magnesium
carbonate, calcium carbonate and the like; alkali metal bicarbonates such as lithium

15

bicarbonate, sodium bicarbonate, potassium bicarbonate and the like.
The hydrolysis step in the present invention can also be carried out in the presence of
“Lewis acids”.
The “Lewis acid” used in the present invention can be selected from but not limited to
LiCl, LiBr, LiI, NaBr, NaI, KBr, KI, CsCl, CsBr, CsI, BeCl2, BeBr2, MgCl2, MgBr2, MgI2,

20

CaCl2, CaBr2, CaI2, ZnCl2, ZnBr2, BaCl2, BaBr2, BaI2, AlCl3, BBr3, BF3, FeCl3 and the like.
The “deprotecting agent” used in the present invention can be selected based on the
protecting group employed. The “deprotecting agent” can be selected from but not limited to
Lewis acids, substituted/unsubstituted C1-C6 straight chain or branched chain alkyl/aryl

25

magnesium halides (Grignard reagent) such as methyl magnesium halide, isopropyl
magnesium halide and the like; acids such as hydrochloric acid, hydrobromic acid, sulfuric
acid, nitric acid, phosphoric acid, trifluoroacetic acid, methanesulfonic acid, ethanesulfonic
acid, benzenesulfonic acid, p-toluenesulfonic acid and the like; acetyl chloride in
combination with alcohols; bases such as alkali metal hydroxides, alkali metal carbonates,

30

cesium carbonate/imidazole, alkali metal bicarbonates, ammonia, aqueous ammonia,
4
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ammonium cerium(IV) nitrate (CAN); and organic bases such as methylamine, ethylamine,
diethylamine, triethylamine, piperidine; hydrogenating agents such as Pd/C, Pd(OH)2/C
(Pearlman‟s catalyst), palladium acetate, platinum oxide, platinum black, Rh/C, Ru, sodium
borohydride, Na-liquid ammonia, Raney-Ni, Zn-acetic acid, tri(C1-C6)alkylsilanes, tri(C1-C6)
5

alkylsilyl halides and the like.
The “dehydrating agent” can be selected from but not limited to propylphosphonic
anhydride

(T3P),

acetic

anhydride,

trifluoroacetic

anhydride

(TFAA),

trifluoromethanesulfonic anhydride, phthalic anhydride, trifluoroacetic acid (TFA), oxalyl
chloride, thionyl chloride, P2O5, phosphoric acid, polyphosphoric acid, POCl3 optionally in
10

presence of imidazole, cyunaric chloride, sulfuric acid, dicyclohexylcarbodiimide (DCC),
carbonyldiimidazole (CDI), sulfuric acid, methanesulfonic acid, p-toluenesulfonic acid,
methanesulfonyl chloride, p-toluenesulfonyl chloride, formic acid, acetyl chloride,
trichloroacetyl chloride, phosgene, diphosgene, triphosgene and the like.

15

The „„coupling agent‟‟ can be selected from Ν,Ν'-dicyclohexylcarbodiimide (DCC),
Ν,Ν'-diisopropylcarbodiimide
hydrochloride

(EDC.HC1),

(DIC),

l-ethyl-3-(3-dimethylaminopropyl)carbodiimide

Ν,Ν'-carbonyl

diimidazole(CDI),

l-[bis(dimethylamino)

methylene] -lH-l,2,3-triazolo[4,5-b]pyridinium 3- oxide hexafluorophosphate (HATU), 2(lH-benzotriazol-l-yl)-l,l,3,3-tetramethyluronium
20

hexafluorophosphate

(HBTU),

lH-

benzotriazolium l-[bis(dimethylamino)methylene]-5- chloro-hexafluorophosphate (1-) 3oxide (HCTU), alkyl/aryl/aralkyl chloroformates such as methyl chloroformate, ethyl
chloroformate, isopropyl chloroformate, phenyl chloroformate, benzyl chloroformate and the
like; diphenylphosphoroazidate (DPPA), thionyl chloride, oxalyl chloride, phosphorous
oxychloride, phosphorous pentachloride, 4-methyl-2- oxopentanoyl chloride (i-BuCOCOCl),

25

(benzotriazol-l-yloxy)tris(dimethylamino)

phosphonium

hexafluorophosphate

(BOP),

benzotriazol-l-yl-oxytripyrrolidinophosphonium hexafluorophosphate (PyBOP), alkyl/aryl
sulfonyl

chlorides

such

as

methanesulfonyl

chloride,

ethanesulfonyl

chloride,

benzenesulfonyl chloride, p-toluenesulfonyl chloride and the like optionally in combination
with 1-hydroxy-7-azatriazole (HOAt), 1-hydroxy benzotriazole (HOBt), l-hydroxy-lH-l,2,330

triazole-4-carboxylate

(HOCt),

O-(benzotriazol-l-yl)-N,N,N',N'-tetramethyluronium
5
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tetrafluoroborate (TBTU), N-hydroxysuccinamide (HOSu), N-hydroxysulfosuccinimide
(Sulfo-NHS) and the like.

The decarboxylation process in the present invention can be carried out by heating the
5

compound in presence of alkali/alkaline earth metal hydroxides.
„Chiral acid‟‟ used in the present invention can be selected from (+)-tartaric acid, (+)malic acid, (+)-mandelic acid, and (+)-camphor-10-sulfonic acid, (+)-tetrahydrofuran-2carboxylic acid, alpha-bromocamphoric acid, methoxyacetic acid, diacetyltartaric acid, di

10

p-toluoyl tartaric acid, dibenzoyl tartaric acid, lactic acid, ibuprofen, pyrrolidone-5carboxylic acid, naproxen, 3-(2-amino-2-oxoethyl)-5-methylhexanoic acid and the like.
In the present invention „PG‟ and „PG1‟ represents „„hydroxyl protecting groups‟‟
which can be selected from but not limited to methyl, ethyl, tert-butyl, acetyl, pivaloyl,

15

benzyl, benzoyl, silyl protecting groups such as trimethylsilyl, triethylsilyl, triisopropylsilyl,
tert-butyldimethylsilyl,

tert-butyldiphenylsilyl

and

the

like;

tetrahydropyranyl,

tetrahydrofuranyl, triphenyl methyl (trityl), methoxymethyl acetal (MOM), methoxypropyl
acetal (MOP), ethoxyethyl acetal, benzyloxymethyl acetal (BOM), methoxymethyl,
benzyloxymethyl, tert-butoxymethyl, methoxyphenyl, methoxytrityl (MMT), dimethoxytrityl
20

(DMT) and the like.
In the present invention „PG2‟ represents “amine protecting group” selected from but
not limited to alkoxycarbonyl such methoxycarbonyl (Moc), ethoxycarbonyl, tertbutyloxycarbonyl (Boc), benzyloxycarbonyl (Cbz), p-methoxybenzyl carbonyl (Moz or

25

MeOZ), 9-fluorenylmethyloxy carbonyl (Fmoc), acetyl (Ac), benzoyl (Bz), benzyl (Bn),
carbamate group, p-methoxyphenyl (PMP), p-methoxybenzyl (PMB), 3,4-dimethoxybenzyl
(DMPM), tosyl (Ts), trifluoroacetyl (TFA), trichloroethoxycarbonyl (Troc), pivaloyl (Piv),
triphenylmethyl (trityl or Trt) and the like.

6
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The first embodiment of the present invention provides a process for the preparation
of compound of formula-1, comprising;
a)

resolution of compound of formula-3 by treating it with a chiral acid to provide
compound of formula-4,

5
Formula-3

Formula-4

wherein, „PG‟ represents hydroxyl protecting group;
b) deprotection of compound of formula-4 with a deprotecting agent followed by reacting
the obtained compound with compound of formula-5 to provide compound of formula-6,

R1-(CH2)n-R2
Formula-5

10

Formula-6

wherein, „R1‟ and „R2‟ are same or different and can be independently selected from OH,
halogens such as F, Cl, Br, I and substituted or unsubstituted alkyl/aryl sulfonyloxy such
as methanesulfonyloxy (OMs), benzenesulfonyloxy, p-toluenesulfonyloxy (OTs) and the
like; and „n‟ is an integer selected from 1 to 10;

15
c)

reacting compound of formula-6 with compound of formula-7 optionally in presence of a
dehydrating agent to provide compound of formula-8,

Formula-7

Formula-8
7
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d) hydrolyzing the compound of formula-8 in presence of an acid, a base or a Lewis acid to
provide compound of formula-2,

Formula-2
5

e)

reacting compound of formula-2 with compound of formula-9 optionally in presence of a
base to provide compound of formula-1.

Formula-9
wherein, „R3‟ is selected from OH, halogens such as F, Cl, Br, I and substituted or
10

unsubstituted

alkyl/aryl

sulfonyloxy

such

as

methanesulfonyloxy

(OMs),

benzenesulfonyloxy, p-toluenesulfonyloxy (OTs) and the like.
The second embodiment of the present invention provides a process for the
preparation of compound of formula-1 involving the use of compound of formula-38 as
15

illustrated in scheme-I, comprising treating compound of formula-4 with a deprotecting agent
to provide compound of formula-38 which on further reaction with compound of formula-7
optionally in presence of a dehydrating agent provides compound of formula-2. This can be
further converted to compound of formula-1 as per the process described above.

20

8
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The third embodiment of the present invention provides another process for the
preparation of compound of formula-1, comprising;
a) reacting compound of formula-10 with compound of formula-11

5

Formula-10

Formula-11

wherein, „R4‟, „R5‟ and „R6‟ are selected from straight or branched chain C1-C6 alkyl;
and „PG1‟ represents hydroxyl protecting group;
optionally in presence of a base to provide compound of formula-12,

10

Formula-12
b) reacting compound of formula-12 with compound of formula-13 optionally in presence
of a base to provide compound of formula-14,

Formula-13
15

Formula-14

wherein, „R7‟, „R8‟ are same or different and can be selected from straight/branched
chain C1-C6 alkyl groups;
c) reacting compound of formula-14 with compound of formula-15 optionally in presence
of a base to provide compound of formula-16,

20

Formula-15

Formula-16

wherein, „PG2‟ represents amine protecting group;
9
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d) treating compound of formula-16 with a deprotecting agent to provide compound of
formula-17,

Formula-17
5

e) reacting compound of formula-17 with compound of formula-18 optionally in presence
of a coupling agent and/or a base to provide compound of formula-19;

Formula-18

Formula-19

f) treating compound of formula-19 with a deprotecting agent followed by cyclization of
10

the obtained compound to provide compound of formula-20,

Formula-20
g) resolution of compound of formula-20 by treating it with a chiral acid to provide
compound of formula-21,

15

Formula-21
h) treating the compound of formula-21 with a deprotecting agent followed by reacting the
obtained compound with CH3-(CH2)n-OH optionally in presence of a base to provide
compound of formula-22,

10
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Formula-22
wherein, „n‟ is an integer selected from 1 to 10;
i) reacting compound of formula-22 with compound of formula-7 optionally in presence
5

of a dehydrating agent to provide compound of formula-23,

Formula-7

Formula-23

j) hydrolyzing the compound of formula-23 in presence of an acid or a base to provide
compound of formula-24,

10
Formula-24
k) hydrolyzing compound of formula-24 in presence of an acid, a base or a Lewis acid
followed by decarboxylation of the obtained compound to provide compound of
formula-2,
15

l) converting the compound of formula-2 to compound of formula-1 as per the process
described above.

11
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The fourth embodiment of the present invention provides a process for the
preparation of compound of formula-1 involving the use of compound of formula-27 as
illustrated in scheme-III, comprising;
a) reacting compound of formula-7 with compound of formula-25 to provide compound of
5

formula-26,

Formula-25
wherein, „R9‟ is selected from straight or branched chain C1-C6 alkyl; and „PG‟
represents hydroxyl protecting group;

10
Formula-26
b) resolution of compound of formula-26 by treating it with a chiral acid to provide
compound of formula-27,

15

Formula-27
c) reacting compound of formula-27 with compound of formula-18 optionally in presence
of a coupling agent and/or a base to provide compound of formula-29,

12
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Formula-18

Formula-29

d) treating compound of formula-29 with a deprotecting agent followed by cyclization of
the obtained compound to provide compound of formula-2,
5

e) converting compound of formula-2 to compound of formula-1 as per the process
described above.

The fifth embodiment of the present invention provides a process for the preparation
of compound of formula-29, comprising hydrolysis of compound of formula-26 followed
10

by resolution by treating with a chiral acid to provide compound of formula-28 which on
reaction with compound of formula-18 optionally in presence of a coupling agent and/or a
base to provide compound of formula-29.

15

20
13
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An embodiment of the present invention provides a process for the preparation of
compound of formula-1, comprising at least one of the following conversions

wherein, R9 is selected from straight/branched chain C1-C6 alkyl;
5

„PG‟ represents „„hydroxyl protecting groups‟‟ which can be selected from methyl, ethyl,
tert-butyl, acetyl, pivaloyl, benzyl, benzoyl, silyl protecting groups such as trimethylsilyl,
triethylsilyl,

triisopropylsilyl,

tert-butyldimethylsilyl,

tert-butyldiphenylsilyl;

tetrahydropyranyl, tetrahydrofuranyl, triphenyl methyl (trityl), methoxymethyl acetal
(MOM), methoxypropyl acetal (MOP), ethoxyethyl acetal, benzyloxymethyl acetal (BOM),
10

methoxymethyl,

benzyloxymethyl,

tert-butoxymethyl,

methoxyphenyl,

methoxytrityl

(MMT), dimethoxytrityl (DMT).

15

14
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The compound of formula-2 obtained by the above described process can be further
converted to compound of formula-1 by reacting compound of formula-2 with compound of
formula-9 optionally in presence of a base

5

Formula-9
wherein, „R3‟ is selected from OH, halogens such as F, Cl, Br, I and substituted or
unsubstituted

alkyl/aryl

sulfonyloxy

such

as

methanesulfonyloxy

(OMs),

benzenesulfonyloxy, p-toluenesulfonyloxy (OTs).

10

Various conversions in the above described process are carried out by using
appropriate reagents/solvents/catalysts etc as described in the present invention and by the
procedures as described herein in the present invention.
The sixth embodiment of the present invention provides a process for the preparation

15

of compound of formula-1 involving the use of compound of formula-33 as illustrated in
scheme-IV, comprising;
a) treating compound of formula-30 with a deprotecting agent followed by reacting the
obtained compound with compound of formula-5 optionally in presence of a base to
provide compound of formula-31,

20
Formula-30

R1-(CH2)n-R2
Formula-5

Formula-31

wherein, „R1‟, „R2‟ are as defined above; „PG1‟ represents hydroxyl protecting group;
R10‟ is selected from straight or branched chain C1-C6 alkyl; „n‟ is as defined above;
b) reacting compound of formula-31 with compound of formula-15 to provide compound of
25

formula-32,

15
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NH2-NH-PG2
Formula-15

Formula-32

wherein, „PG2‟ represents amine protecting group;
c) reacting compound of formula-32 with compound of formula-18 optionally in presence
5

of a coupling agent and/or a base to provide compound of formula-33,

Formula-18

Formula-33

d) treating compound of formula-33 with a deprotecting agent followed by cyclization of
the obtained compound to provide compound of formula-34,

10
Formula-34
e) resolution of compound of formula-34 by treating it with a chiral acid to provide
compound of formula-6,

16
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Formula-6
f) converting compound of formula-6 to compound of formula-1 as per the process
described above.
5

The seventh embodiment of the present invention provides a process for the
preparation of compound of formula-1 involving the use of compound of formula-35 as
illustrated in scheme-IV, comprising;
a) reacting compound of formula-32 with compound of formula-37 optionally in presence

10

of a coupling reagent and/or a base to provide compound of formula-35,

Formula-32

Formula-37

wherein, „R10‟ is as defined above; „R11 is selected from hydrogen, C1-C6 straight chain
or branched chain alkyl, aryl or aralkyl groups;

15
Formula-35
17
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b) treating compound of formula-35 with a deprotecting agent followed by cyclization of
the obtained compound to provide compound of formula-36,

Formula-36
5

c) decarboxylation of compound of formula-36 (if R11= H) or hydrolysis of compound of
formula-36 followed by decarboxylation of the obtained compound (if R11≠ H) to
provide compound of formula-6,
d) converting compound of formula-6 to compound of formula-1 as per the process
described above.
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The present invention is schematically represented as follows:
Scheme-I:
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Scheme-II:

5

10

20

https://www.tdcommons.org/dpubs_series/4957

21

Thirumalai Rajan et al.: Processes For The Preparation of ({(12aR)-12-[(11S)-7,8-difluoro-

Scheme-III:

Scheme-IV:
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In the above schemes-I, II, III and IV, „n‟ is an integer selected from 1 to 10;
„R1‟ and „R2‟ are same or different and can be independently selected from OH, halogens
such as F, Cl, Br, I and substituted or unsubstituted alkyl/aryl sulfonyloxy such as
methanesulfonyloxy (OMs), benzenesulfonyloxy, p-toluenesulfonyloxy (OTs) and the like;
5

„R3‟ is selected from OH, halogens such as F, Cl, Br, I and substituted or unsubstituted
alkyl/aryl

sulfonyloxy

such

as

methanesulfonyloxy

(OMs),

benzenesulfonyloxy,

p-toluenesulfonyloxy (OTs) and the like;
R4, R5, R6, R7, R8, R9, R10 are independently selected from straight/branched chain C1-C6
alkyl; R11 is selected from H, C1-C6 straight/branched chain alkyl, aryl or aralkyl groups;
10

„PG‟ and „PG1‟ represents „„hydroxyl protecting groups‟‟ which can be selected from but not
limited to methyl, ethyl, tert-butyl, acetyl, pivaloyl, benzyl, benzoyl, silyl protecting groups
such

as

trimethylsilyl,

triethylsilyl,

triisopropylsilyl,

tert-butyldimethylsilyl,

tert-

butyldiphenylsilyl and the like; tetrahydropyranyl, tetrahydrofuranyl, triphenyl methyl
(trityl), methoxymethyl acetal (MOM), methoxypropyl acetal (MOP), ethoxyethyl acetal,
15

benzyloxymethyl acetal (BOM), methoxymethyl, benzyloxymethyl, tert-butoxymethyl,
methoxyphenyl, methoxytrityl (MMT), dimethoxytrityl (DMT) and the like;
„PG2‟ represents “amine protecting group” selected from but not limited to alkoxycarbonyl
such

methoxycarbonyl

(Moc),

ethoxycarbonyl,

tert-butyloxycarbonyl

(Boc),

benzyloxycarbonyl (Cbz), p-methoxybenzyl carbonyl (Moz or MeOZ), 9-fluorenylmethyloxy
20

carbonyl (Fmoc), acetyl (Ac), benzoyl (Bz), benzyl (Bn), carbamate group, p-methoxyphenyl
(PMP), p-methoxybenzyl (PMB), 3,4-dimethoxybenzyl (DMPM), tosyl (Ts), trifluoroacetyl
(TFA), trichloroethoxycarbonyl (Troc), pivaloyl (Piv), triphenylmethyl (trityl or Trt) and the
like.
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